ArticleMolecular cancer therapeutics2018

Intra versus Inter Cross-resistance Determines Treatment Sequence between Taxane and AR-Targeting Therapies in Advanced Prostate Cancer.

Alan P Lombard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.